{{Rsnum
|rsid=12147450
|Chromosome=14
|position=20489274
|Orientation=plus
|GMAF=0.1345
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 32.7 | 62.8
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.0 | 4.4 | 95.6
| YRI | 2.0 | 35.4 | 62.6
| ASW | 1.8 | 33.3 | 64.9
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 2.1 | 26.8 | 71.1
| LWK | 0.0 | 20.0 | 80.0
| MEX | 5.3 | 28.1 | 66.7
| MKK | 0.0 | 29.1 | 70.9
| TSI | 1.0 | 33.0 | 66.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=6E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12147450
|overall_frequency_n=24
|overall_frequency_d=126
|overall_frequency=0.190476
|n_genomes=16
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}